Healthcare technology provider Tempus AI raises $410M in IPO

June 14, 2024: Tempus AI Nets $410M in Soaring IPO - Tempus AI Inc., a leading healthcare technology firm, surged in its Nasdaq debut, raising $410 million from an IPO priced at $37 per share, hitting the upper end of its target range. Founded by Eric Lefkofsky in 2015, the company, valued at about $6.65 billion, specializes in medical testing and clinical software, serving over 7,000 physicians across many institutions. With a focus on optimizing treatment plans through its extensive clinical and molecular oncology data library, Tempus AIs revenue climbed to $531.8 million last year, aiming to further develop AI-driven diagnostics.